Gene55352
COPRS: coordinator of PRMT5 and differentiation stimulator
Cite this record
ConductScience Library. COPRS: coordinator of PRMT5 and differentiation stimulator. Genes, record 55352. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/55352
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NQ92 | Coordinator of PRMT5 and differentiation stimulator | 184 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents38
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260227408 A1 | 2026-08-06 | 4795 | Q9NQ92 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4267 | Q9NQ92 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4795 | Q9NQ92 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 4267 | Q9NQ92 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4267 | Q9NQ92 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 2455 | Q9NQ92 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 2455 | Q9NQ92 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4795 | Q9NQ92 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 11533 | Q9NQ92 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 198230 | Q9NQ92 | Espacenet |
NIH grants138
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | COPRS papers | Newest fiscal year |
|---|---|---|---|
| P30CA013330 | Cancer Center Support Grant | 2 | 2025 |
| P30CA023168 | Cancer Center Support Grant | 2 | 2025 |
| P30CA082709 | Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant | 2 | 2025 |
| R01CA233626 | The function of the PRMT5 methylosome in MTAP deleted cancers | 2 | 2025 |
| P01CA019014 | Viral Oncogenesis, Latency, and Replication | 1 | 2025 |
| P01CA100730 | Retrovirus Models of Cancer | 1 | 2025 |
| P20GM103395 | Alaska INBRE 5 One Health | 1 | 2025 |
| P20GM103506 | New Hampshire IDeA Network of Biomedical Research Excellence (NH-INBRE) | 1 | 2025 |
| P20GM113131 | Center of Integrated Biomedical and Bioengineering Research (CIBBR) | 1 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 1 | 2025 |
Source NIH's project files
Papers139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein arginine methyltransferase 5 sustains Tip60-EP400 complex via SRSF1 in Merkel cell carcinoma. | Life Sci Alliance | 2025 | 40846633 | PubTator, text mining | PubMed |
| Substrate adaptors are flexible tethering modules that enhance substrate methylation by the arginine methyltransferase PRMT5. | J Biol Chem | 2025 | 39793893 | PubTator, text mining | PubMed |
| Genetic and environmental associations of nonspecific chromosomal aberrations. | Mutagenesis | 2025 | 38422374 | PubTator, text mining | PubMed |
| Cross-regulation and cross-talk of conserved and accessory two-component regulatory systems orchestrate Pseudomonas copper resistance. | PLoS Genet | 2024 | 38861577 | PubTator, text mining | PubMed |
| PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma. | Cancers (Basel) | 2023 | 38136401 | PubTator, text mining | PubMed |
| Carcinogenesis and Prognostic Utility of Arginine Methylation-Related Genes in Hepatocellular Cancer. | Curr Issues Mol Biol | 2023 | 38132437 | PubTator, text mining | PubMed |
| Protein arginine methylation in viral infection and antiviral immunity. | Int J Biol Sci | 2023 | 37928266 | PubTator, text mining | PubMed |
| The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality. | Front Oncol | 2023 | 37795443 | PubTator, text mining | PubMed |
| Mining-related multi-resistance genes in sulfate-reducing bacteria treatment of typical karst nonferrous metal(loid) mine tailings in China. | Environ Sci Pollut Res Int | 2023 | 37707732 | PubTator, text mining | PubMed |
| Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer. | Res Sq | 2023 | 37502925 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55352
GET https://conductscience.org/api/genes/v1/55352/patents?page=2